Organisation paid for research Program year 2023 Source: CMS Open Payments

Western Institutional Review B

Neither a doctor nor a teaching hospital

Research payments

$67,120

42 payments

Through program year 2023, Western Institutional Review B is reported as receiving $67,120 in research payments, across 42 payments.

By program year

3 rows
Year Kind Amount Payments
2023 Research $10,380 7
2022 Research $32,965 21
2021 Research $23,775 14

Breakdown

Who paid Research payments · program years 2021–2023
  1. Retrophin, Inc. $53,035 32 payments
  2. Genentech, Inc. $7,435 3 payments
  3. Ge Healthcare $5,045 3 payments
  4. Takeda Pharmaceuticals U.S.A., Inc. $1,605 4 payments
Studies the money was for Research payments · program years 2021–2023
  1. A Phase 3 Study to Evaluate the Effects of Chenodal in Adult and Pediatric Patients With Cerebrotendinous Xanthomatosis $50,580 29 payments
  2. Nautika1 Previously Lcmc4 $7,435 3 payments
  3. External Evaluation of Mac 5 Resting Ecg Analysis System $3,730 1 payment
  4. Cbs-Hcy-Ct-01 $2,455 3 payments
  5. Mac-Lab/Cardiolab V8.0 System Performance Evaluation $1,315 2 payments
  6. A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Dose Ranging Study to Evaluate the Efficacy and Safety of 2 Dose Regimens of Intravenous Tak-954 for the Prophylaxis and Treatment of Postoperative Gastrointestinal Dysfunction in Patients Undergoing Large- and Small-Bowel Resection $1,115 3 payments
  7. An Open-Label, Single-Arm, Multicenter Study to Evaluate the Effectiveness and Safety of Ixazomib (Ninlaro?) in Combination With Lenalidomide and Dexamethasone (Ird) in Patients With Multiple Myeloma Previously Receiving A Bortezomib-Based Induction Regimen (US Mm-6) $490 1 payment
What the money was spent on Research payments · program years 2021–2023
  1. Other $53,035 32 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record